SMAIO SA

PA:ALSMA France Health Information Services
Market Cap
$42.22 Million
€41.13 Million EUR
Market Cap Rank
#29626 Global
#306 in France
Share Price
€7.30
Change (1 day)
+0.69%
52-Week Range
€3.30 - €8.65
All Time High
€8.65
About

S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. It offers solutions for surgeons including programs for training, assistance with surgical planning based on a database called KEOPS. The company also offers solutions such as i-PLAN, take control of the realignment plan; i-PERFORM, take control of the surgical plan; i-CHE… Read more

SMAIO SA (ALSMA) - Net Assets

Latest net assets as of June 2025: €7.41 Million EUR

Based on the latest financial reports, SMAIO SA (ALSMA) has net assets worth €7.41 Million EUR as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€13.82 Million) and total liabilities (€6.42 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €7.41 Million
% of Total Assets 53.59%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 56.08

SMAIO SA - Net Assets Trend (2018–2024)

This chart illustrates how SMAIO SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for SMAIO SA (2018–2024)

The table below shows the annual net assets of SMAIO SA from 2018 to 2024.

Year Net Assets Change
2024-12-31 €6.85 Million -36.62%
2023-12-31 €10.80 Million +10.86%
2022-12-31 €9.75 Million +1674.73%
2021-12-31 €-618.89K -41.34%
2020-12-31 €-437.87K -124.51%
2019-12-31 €1.79 Million +440.49%
2018-12-31 €-524.71K --

Equity Component Analysis

This analysis shows how different components contribute to SMAIO SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 176413400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock €993.44K 14.51%
Other Components €8.20 Million 119.79%
Total Equity €6.85 Million 100.00%

SMAIO SA Competitors by Market Cap

The table below lists competitors of SMAIO SA ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in SMAIO SA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 10,804,334 to 6,847,938, a change of -3,956,396 (-36.6%).
  • Net loss of 2,348,850 reduced equity.
  • Share repurchases of 87,200 reduced equity.
  • New share issuances of 34,346 increased equity.
  • Other factors decreased equity by 1,554,692.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €-2.35 Million -34.3%
Share Repurchases €87.20K -1.27%
Share Issuances €34.35K +0.5%
Other Changes €-1.55 Million -22.7%
Total Change €- -36.62%

Book Value vs Market Value Analysis

This analysis compares SMAIO SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 5.56x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-12-31 €-0.10 €7.30 x
2019-12-31 €0.34 €7.30 x
2020-12-31 €-0.08 €7.30 x
2021-12-31 €-0.12 €7.30 x
2022-12-31 €1.87 €7.30 x
2023-12-31 €2.07 €7.30 x
2024-12-31 €1.31 €7.30 x

Capital Efficiency Dashboard

This dashboard shows how efficiently SMAIO SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -34.30%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -42.73%
  • • Asset Turnover: 0.47x
  • • Equity Multiplier: 1.72x
  • Recent ROE (-34.30%) is below the historical average (-14.82%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 0.00% -339.43% 0.06x 0.00x €-510.84K
2019 -94.52% -432.84% 0.10x 2.15x €-1.87 Million
2020 0.00% -180.48% 0.19x 0.00x €-2.18 Million
2021 0.00% -145.39% 0.26x 0.00x €-3.03 Million
2022 29.20% 116.54% 0.20x 1.23x €1.87 Million
2023 -4.13% -8.29% 0.36x 1.40x €-1.53 Million
2024 -34.30% -42.73% 0.47x 1.72x €-3.03 Million

Industry Comparison

This section compares SMAIO SA's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $52,946,360
  • Average return on equity (ROE) among peers: -51.83%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
SMAIO SA (ALSMA) €7.41 Million 0.00% 0.87x $7.78 Million
AbL Diagnostics SA (ABLD) $7.09 Million -0.80% 0.02x $401.58K
AMA Corp PLC (ALAMA) $26.90 Million -36.57% 0.42x $2.09 Million
Intrasense (ALINS) $1.65 Million -341.90% 3.65x $4.69 Million
Cegedim S.A. (CGM) $242.05 Million 13.91% 4.36x $55.75 Million
Equasens S. A. (EQS) $38.61 Million 23.58% 1.03x $174.86 Million
Media Lab SpA (MLLAB) $1.37 Million 30.81% 0.42x $31.45K